GPT and cancer: Furthermore, we determine synergistic interactions between ponatinib and other anti-cancer drugs, such as DNA synthesis inhibitor, triciribine, and ATM inhibitor, KU-60019, and show that combining ponatinib and triciribine is highly effective in killing ALT cells.